Eric Santoni Rugiu

Eric Santoni Rugiu

Clinical Associate Professor

Member of:

  • Pathology

ORCID: 0000-0002-2283-3535

Publication year:
All
91 - 100 out of 144Page size: 10
  1. 2012
  2. Published

    The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas

    Zimling, Z. G., Jørgensen, A. & Santoni Rugiu, Eric, 2012, In: Histopathology. 60, 6B, p. E96-105

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Urokinase plasminogen activator receptor on invasive cancer cells: A prognostic factor in distal gastric adenocarcinoma

    Alpizar-Alpizar, W., Christensen, I. J., Santoni Rugiu, Eric, Skarstein, A., Ovrebo, K., Illemann, M. & Laerum, O. D., 2012, In: International Journal of Cancer. 131, 4, p. E329-E336

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Usikkerhed om behandlingsstrategien ved tymomer

    Abildgaard, J., Pappot, H., Petersen, P. M., Rørth, M., Pedersen, J. H., Santoni Rugiu, Eric & Daugaard, G., 2012, In: Ugeskrift for Laeger. 174, 50, p. 3164-3169 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. 2011
  6. Published

    AN IMMUNOHISTOCHEMICAL PROFILE FOR PREDICTING RESPONSE TO CISPLATIN/VINORELBINE THERAPY IN MALIGNANT PLEURAL MESOTHELIOMA

    Zimling, Z. G., Bech, C., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2011, In: Journal of Thoracic Oncology.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    C4.4A IS A PROGNOSTIC INDICATOR IN NON-SMALL CELL LUNG CANCER PATIENTS WITH ADENOCARCINOMAS

    Jacobsen, B., Muley, T., Meister, M., Dienemann, H., Christensen, I. J., Santoni Rugiu, Eric, Laerum, O. D. & Ploug, Michael, 2011, In: Journal of Thoracic Oncology.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    C4.4A as a biomarker for poor prognosis in non-small cell lung cancer patients with adenocarcinomas

    Jacobsen, B., Muley, T., Meister, M., Dienemann, H., Christensen, I. J., Santoni Rugiu, Eric, Laerum, O. D. & Ploug, Michael, 2011, In: European Journal of Cancer.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    CLASS III beta-TUBULIN, HISTOPATHOLOGY AND QUALITY OF LIFE IN ADVANCED NSCLC PATIENTS RANDOMIZED IN A LARGE MULTICENTER PHASE III TRIAL

    Vilmar, A., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2011, In: Journal of Thoracic Oncology.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Class III beta-Tubulin in Advanced NSCLC of Adenocarcinoma Subtype Predicts Superior Outcome in a Randomized Trial

    Vilmar, A. C., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2011, In: Clinical Cancer Research.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Class III β-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial

    Vilmar, A. C., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2011, In: Clinical Cancer Research. 17, 15, p. 5205-14 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Immunohistochemical detection of ERCC1 and class III beta-tubulin in 54 malignant pleural mesotheliomas treated with cisplatin and vinorelbine: association with treatment response and survival

    Zimling, Z. G., Bech, C., Sørensen, Jens Benn & Santoni Rugiu, Eric, 2011, In: APMIS.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...6 7 8 9 10 11 12 13 ...15 Next

ID: 10801856